AQR Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $66.4K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $425K | Sell |
|
|||||
|
2024
Q1 | $759K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $162K | Buy |
|
|||||
|
2022
Q4 | $226K | Buy |
|
|||||
|
2022
Q3 | $176K | Buy |
|
|||||
|
2022
Q2 | $150K | Sell |
|
|||||
|
2022
Q1 | $186K | Sell |
|
|||||
|
2021
Q4 | $290K | Sell |
|
|||||
|
2021
Q3 | $1.07M | Buy |
|
|||||
|
2021
Q2 | $531K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $274K | Sell |
|
|||||
|
2017
Q2 | $294K | Buy |
|